Anika Therapeutics (ANIK) Return on Invested Capital (2011 - 2026)

Anika Therapeutics (ANIK) has 16 years of Return on Invested Capital data on file, last reported at 0.06% in Q1 2026.

• Return on Invested Capital for Q1 2026 came in at 0.06%, down 6.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.06% (down 6.0% YoY), and the FY2025 annual result was 0.0%, changed 0.0% from the prior year.
• Return on Invested Capital retreated to 0.06% in Q1 2026 per ANIK's latest filing, from 0.0% in the prior quarter.
• Over five years, Return on Invested Capital peaked at 0.0% in Q3 2024 and troughed at 0.06% in Q1 2026.
• A 5-year average of 0.0% and a median of 0.0% in 2023 frame the typical range for Return on Invested Capital.
• The sharpest annual moves came in 2022 and 2026: Return on Invested Capital changed 0 bps in 2022, then dropped 6 bps in 2026.
• A 5-year view of Return on Invested Capital shows it stood at 0.0% in 2022, then jumped by 98 bps to 0.0% in 2023, then sank by 2588 bps to 0.0% in 2024, then soared by 74 bps to 0.0% in 2025, then tumbled by 30655 bps to 0.06% in 2026.
• Business Quant data shows ANIK's Return on Invested Capital at 0.06% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.